Network origin in Johannes Streffer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Johannes Streffer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
| GERON CORPORATION | Biotechnology | Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman | |
| PERSONALIS, INC. | Medical/Nursing Services | Director/Board Member | |
| SWISS LIFE HOLDING AG | Life/Health Insurance | Director/Board Member | |
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
| University of Tilburg | College/University | Corporate Officer/Principal | |
| University of Delaware | College/University | Undergraduate Degree | |
Ethicon, Inc.
 Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Medical Specialties | Director of Finance/CFO | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Zurich | College/University | Undergraduate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal | |
| University of Bern | College/University | Undergraduate Degree | |
| OXURION NV | Pharmaceuticals: Major | Chief Executive Officer | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HUBER+SUHNER (UK) Ltd.
 HUBER+SUHNER (UK) Ltd. Electronic Production EquipmentElectronic Technology HUBER+SUHNER (UK) Ltd. manufactures, imports, and sells electrical and optical connectivity components and accessories. It offers radio frequency and fiber optic products including antennas, assemblies, cables, connectors and adapters, lightning and EMP protectors, and resistive components. The company was founded on March 30, 1967 and is headquartered in Bicester, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
| Tibotec Pharmaceuticals | Director of Finance/CFO | ||
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
| Schweizerische Management Gesellschaft | Director/Board Member | ||
| Gebert Rüf Stiftung | Corporate Officer/Principal | ||
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
| Max Schmidheiny-Stiftung | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| Oxford University Medical School | College/University | Doctorate Degree | |
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| Swiss Society of Economics & Statistics | President | ||
| Richard Büchner Foundation | Director/Board Member | ||
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director of Finance/CFO | |
Heidelberg Instruments Nano AG
 Heidelberg Instruments Nano AG Information Technology ServicesTechnology Services Heidelberg Instruments Nano AG designs and develops nanolithography technology. The firm offers NanoFrazor Systems, NanoFrazor Software. NanoFrazor Cantilevers, and NanoFrazor Resists. The company was founded by Felix Holzner and Philip Paul in 2012 and is headquartered in Zurich, Switzerland. | Information Technology Services | Director/Board Member | |
Mogrify Ltd.
 Mogrify Ltd. BiotechnologyHealth Technology Mogrify Ltd. engages in the development of direct cellular conversion technology. It applies its technology to generate internet protocol and cell types that will power the development and manufacture of new cell therapies in any therapeutic area. The company was founded by Julian Gough, Owen John Llewellyn Rackham, and Jose Polo in 2009 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| Suva City Council | Corporate Officer/Principal | ||
| ViiV Healthcare Co. | Corporate Officer/Principal |
Statistics
International
| Switzerland | 21 |
| United States | 18 |
| United Kingdom | 5 |
| Netherlands | 3 |
| Denmark | 2 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 9 |
| Finance | 3 |
| Electronic Technology | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 43 |
| Corporate Officer/Principal | 23 |
| Independent Dir/Board Member | 14 |
| Chairman | 8 |
| Director of Finance/CFO | 6 |
Most connected contacts
| Insiders | |
|---|---|
| Alan Colowick | 27 |
| Monika Bütler | 25 |
| Martin Velasco | 15 |
| Thomas Graney | 11 |
| Monica Shaw | 8 |
| Peter Bollmann | 4 |
| Howard Donovan | 2 |
- Stock Market
- Insiders
- Johannes Streffer
- Company connections